Table 1.
Characteristic | Pembro | Nivo | Ipi+ Nivo | Total |
---|---|---|---|---|
Number | 18 | 9 | 26 | 53 |
Age, years | ||||
Median (range) | 62 (32–82) | 60 (42–81) | 58 (34–78) | 60 (32–82) |
Gender, n(%) | ||||
Female | 10(56) | 9(100) | 15(58) | 34(64) |
Male | 8(44) | 0 (0) | 11(42) | 19(36) |
Malignancy, n(%) | ||||
Melanoma | 12(67) | 3(33) | 21(81) | 36(68) |
Leiomyosarcoma | 1(6) | 0(0) | 0(0) | 1(2) |
Breast cancer | 3(17) | 0(0) | 0(0) | 3(6) |
Lung cancer | 1(6) | 0(0) | 0(0) | 1(2) |
Glioblastoma | 1(6) | 2(22) | 0(0) | 3(6) |
Renal cell carcinoma | 0(0) | 0(0) | 1(4) | 1(2) |
Meningioma | 0(0) | 3(33) | 0(0) | 3(6) |
Bladder cancer | 0(0) | 1(11) | 1(0) | 2(4) |
Ovarian cancer | 0(0) | 0(0) | 2(0) | 2(4) |
Malignant neoplasm of esophagus | 0(0) | 0(0) | 1(4) | 1(2) |
Preexisting thyroid disorder, n(%) | ||||
Yes | 4(22) | 3(33) | 1(4) | 8(15) |
No | 14(78) | 6(67) | 25(96) | 45(85) |